Citadel Advisors »

Rigel Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $314k 19k 16.18
2024-06-30 $265k 32k 8.22

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Morgan Stanley
Invesco
Soleus Capital Management
Vanguard Group
Susquehanna International
Assenagon Asset Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
CM Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals